Alex Nowark

Q: What is Alex Nowark's success rate?

Alex Nowark currently has a success rate of 67.82222222222222.

Q: What is the average return of Alex Nowark's calls?

Their stock ratings have generated an average return of 22.540062879751307.

LUCID CAPITAL MARKETS | Healthcare

Alex Nowark is an analyst from LUCID CAPITAL MARKETS specializing in the Healthcare sector. Ranked #1950 out of 4758 analysts, they have issued 5 stock ratings with a success rate of 67.82% and an average return of 22.54%.

With 5 ratings to date, Alex Nowark is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 67.82% and an average return of 22.54%, highlighting promising potential as their track record develops further.

#1950

Out of 4758

Total Ratings

+67.82%

Success Rate

+22.54%

Average Return

Recent Ratings Analysis

IMDX

Buy

Aug 24, 2026

Target

$8.00

Current

$4.32

Performance

0.00%

Alex Nowark rated IMDX as Buy on Aug 24, 2026, setting a price target of 8. Shares have remained stable near 4.32, leaving the 8 target still in play.

COCH

Buy

Jul 27, 2026

Target

$2.00

Current

$0.75

Performance

10.71%

On Jul 27, 2026, COCH was given a Buy rating by Alex Nowark, with a target price of 2. The stock rallied 10.71% after the rating, narrowing the gap to the target of 2 and validating the bullish stance.

MBOT

Buy

Jun 03, 2026

Target

$4.00

Current

$1.48

Performance

-24.87%

MBOT received a Buy rating from Alex Nowark on Jun 03, 2026, aiming for 4. The rating hasn’t played out as hoped, with the stock trading 24.87% below expectations.

ADGM

Buy

Jun 03, 2026

Target

$3.00

Current

$0.59

Performance

-21.32%

On Jun 03, 2026, Alex Nowark published a Buy outlook on ADGM, with a target of 3. Market action contradicted the Buy thesis, as shares slipped to 0.5901.

SSII

Buy

Jun 03, 2026

Target

$7.00

Current

$3.50

Performance

-18.79%

Alex Nowark on Jun 03, 2026 assigned SSII a Buy rating, with a price target of 7. The call has struggled to gain traction, with shares losing 18.79%.

EXAS

Buy

Sep 11, 2025

Target

$85.00

Current

$104.91

Performance

87.34%

On Sep 11, 2025, Alex Nowark reaffirmed EXAS with a Buy rating, targeting 85. The recommendation was supported by strong follow-through as the stock rose from 104.91 to 104.91.

NEO

Buy

May 01, 2024

Target

$26.00

Current

$16.41

Performance

17.55%

NEO was rated Buy by Alex Nowark on May 01, 2024, with a price objective of 26. A bullish response from the market helped close the gap of 9.59 to the target.

GH

Buy

Apr 24, 2024

Target

$28.00

Current

$163.18

Performance

801.55%

On Apr 24, 2024, Alex Nowark initiated coverage on GH with a Buy rating and target of 28. The stock’s climb of 801.55% since the call highlights the foresight in the rating.

Frequency Asked Questions

Who is Alex Nowark?

Alex Nowark is an analyst from LUCID CAPITAL MARKETS specializing in the Healthcare sector.

What is Alex Nowark's success rate?

Alex Nowark currently has a success rate of +67.82%.

How many ratings has Alex Nowark issued?

Alex Nowark has issued 5 stock ratings so far.

What is the average return of Alex Nowark's calls?

Their stock ratings have generated an average return of +22.54%.

What is Alex Nowark's ranking?

Alex Nowark is ranked #1950 out of 4758 analysts.

What types of ratings does Alex Nowark give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Alex Nowark?

You can follow Alex Nowark by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Alex Nowark?

Their latest rating was a Buy on IMDX issued on 2026-08-24.